US FDA Announced, Blood Pressure Medicine Recalled Due to Potential Cancer Risk

The US Food and Drug Administration (FDA), announced that the pharmaceutical company Aurobindo Pharma is recalling a blood pressure medication because of a potential cancer risk. The company is recalling two lots of quinapril and hydrochlorothiazide tablets because of the levels of nitrosamine. The tablets are most commonly prescribed for the treatment of hypertension to […]

Continue Reading

US FDA Approved Zhiyi Biotech’s SK10 to Treat Chemotherapy-induced Diarrhea

Zhiyi Biotech has announced that the US Food and Drug Administration (FDA) has approved the Investigational New Drug (IND) application of the company to develop SK10 (Inactivated Bacteroids fragilis) for the treatment of Chemotherapy-induced Diarrhea (CID). The approval of the IND application authorizes Zhiyi Biotech to conduct a Phase 1 clinical trial in the United […]

Continue Reading

SpectrumX Launches Sporicidal Body Wash for Healthcare Facilities in UK

SpectrumX, a healthcare and pharmaceutical company based in the UK, announces the launch of Spectricept HLD Body MIST, a skin-safe sporicidal disinfectant body wash that targets pathogen, including Clostridiodes difficile spores that can lead to an antimicrobial-resident bacterium causing diarrhoea, and other severe health-related issues. Clostridiodes difficile can be the main reason of persistent waves […]

Continue Reading

BioExcel Diagnostics, Takara Bio USA, Inc. Partner to Develop Infectious Disease Detection Panel

Takara Bio USA, Inc., a life science reagent and instrument company, partnered with BioExcel Diagnostics to develop and validate a new comprehensive method for detecting syndrome-based infectious diseases. This method employs real-time PCR automation technology and reagents from Takara Bio for detection of bacteria, viruses, fungi, and antimicrobial resistance genes, which are specific to the […]

Continue Reading

US FDA authorized Updated COVID-19 Booster Shots for Children Above 5 years

The US Food and Drug Administration (FDA) has authorized updated COVID-19 booster vaccine shots developed by Moderna and Pfizer/BioNTech, for children aged five years and above to enhance protection against the COVID-19 virus. The US FDA has updated the emergency use authorizations for the Modern COVID-19 vaccine, and the Pfizer/BioNTech COVID-19 vaccine, bivalent to approve […]

Continue Reading